Literature DB >> 14616702

Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice.

N Bourne1, L J D Zaneveld, J A Ward, J P Ireland, L R Stanberry.   

Abstract

OBJECTIVE: To investigate the in vivo activity of poly(sodium 4-styrene sulfonate) (T-PSS) gel formulations as topical microbicides.
METHODS: The ability of the gel formulations to reduce the incidence of infection when applied prior to pathogen challenge was examined in mouse models of vaginal herpes simplex type 2 (HSV-2) and Chlamydia trachomatis infection, and rectal HSV-2 infection.
RESULTS: In the vaginal HSV-2 challenge studies, 10% T-PSS gel provided significant protection against infection, even when administered 60 min prior to virus challenge (P < 0.0001). Both 5% and 10% T-PSS gel formulations significantly reduced the incidence of upper genital tract C. trachomatis infection in animals treated up to 5 min before challenge (P < 0.001). However, no protection against C. trachomatis infection was seen in animals treated 30 min before challenge. In mice challenged rectally with HSV-2, both the 5% and 10% T-PSS gels significantly reduced infection at 20 s (P < 0.01 for both). However, only the 10% gel provided significant protection when administered 5 min before challenge (P < 0.01).
CONCLUSIONS: T-PSS gel formulations have promising in vivo activity as topical microbicides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616702     DOI: 10.1046/j.1469-0691.2003.00659.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.

Authors:  Valence M K Ndesendo; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Eckhart Buchmann; Leith C R Meyer; Riaz A Khan; Uwe Rosin
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

2.  Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection.

Authors:  Nigel Bourne; Rachael Stegall; Raquel Montano; Michael Meador; Lawrence R Stanberry; Gregg N Milligan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.

Authors:  Christine K Mauck; Debra H Weiner; Susan A Ballagh; Mitchell D Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Jaim-Jou Lai; William F Rencher; Marianne M Callahan
Journal:  Contraception       Date:  2004-07       Impact factor: 3.375

4.  High-throughput multistrain polymerase chain reaction quantification of Chlamydia trachomatis from clinical and preclinical urogenital specimens.

Authors:  Chris L McGowin; Gregory C Whitlock; Richard B Pyles
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 2.803

5.  Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor.

Authors:  Amit Balakrishnan; Lingling Wang; Xiaojin Li; Pamela Ohman-Strickland; Paul Malatesta; Huizhou Fan
Journal:  Microbiol Res       Date:  2007-10-23       Impact factor: 5.415

6.  Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.

Authors:  Suiyi Tan; Lu Lu; Lin Li; Jixiang Liu; Yelena Oksov; Hong Lu; Shibo Jiang; Shuwen Liu
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

7.  A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days.

Authors:  Craig R Cohen; Joelle Brown; Anna-Barbara Moscicki; Elizabeth A Bukusi; Jeremy R A Paull; Clare F Price; Stephen Shiboski
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

8.  Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.

Authors:  Richard A Cone; Timothy Hoen; Xixi Wong; Raed Abusuwwa; Deborah J Anderson; Thomas R Moench
Journal:  BMC Infect Dis       Date:  2006-06-01       Impact factor: 3.090

9.  Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.

Authors:  Yejin Jang; Heegwon Shin; Myoung Kyu Lee; Oh Seung Kwon; Jin Soo Shin; Yong-Il Kim; Chan Woo Kim; Hye-Ra Lee; Meehyein Kim
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

10.  A Synthetic, Small, Sulfated Agent Is a Promising Inhibitor of Chlamydia spp. Infection in vivo.

Authors:  Karen M Gallegos; Christopher R Taylor; Daniel J Rabulinski; Rosalinda Del Toro; Danielle E Girgis; Dapinder Jourha; Vaibhav Tiwari; Umesh R Desai; Kyle H Ramsey
Journal:  Front Microbiol       Date:  2019-01-16       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.